Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  fluorescent imaging ligand OTL38
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Fluorescent Imaging Ligand OTL38 in Imaging Tumors in Patients with Kidney Cancer Undergoing Surgery
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: IUSCC-0546, NCI-2017-00274, NCT02645409
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 to 85
Trial IDs: OTL-2016-OTL38-005, NCI-2017-01204, NCT02872701
OTL38 in Imaging Patients with Suspected Pituitary Adenoma Undergoing Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC 18315, NCI-2015-01600, 822782, NCT02769533
Start Over